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Abstract
Vitamin K intake has been reported as an essential factor for bone formation. The current study was conducted under the hypothesis that insufficient
vitamin K intake would affect inflammatory markers and bone mineral density in young adult women. The study was a cross-sectional design that
included 75 women in their 20s. Physical assessments, bone mineral density measurements, 24-hr dietary recalls, and biochemical assessments for
high sensitivity C-reactive protein (hs-CRP) and percentages of undercarboxylated osteocalcin (%ucOC) were performed. An analysis of vitamin
K nutritional status was performed comparing first, second, and third tertiles of intake based on %ucOC in plasma. Vitamin K intake levels in
the first, second, and third tertiles were 94.88 ± 51.48 μg, 73.85 ± 45.15 μg, and 62.58 ± 39.92 μg, respectively (P < 0.05). The T-scores of the first 
and third tertiles were 1.06 and -0.03, respectively, indicating that bone mineral density was significantly lower in the group with lower vitamin 
K intake (P< 0.05). There was a tendency for different serum hs-CRP concentrations between the first (0.04 ± 0.02) and third tertiles (0.11 ± 0.18),
however this was not statistically significant. Regression analysis was performed to identify the correlations between vitamin K nutritional status,
inflammatory markers, and bone mineral density after adjusting for age and BMI. Serum hs-CRP concentrations were positively correlated with
vitamin K deficiency status (P< 0.05). And bone mineral density, which was represented by speed, was negatively correlated with vitamin K deficiency
status (P< 0.05). In conclusion, status of vitamin K affects inflammatory status and bone formation. Therefore, sufficient intake of vitamin K is
required to secure peak bone mass in young adult women.
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Introduction9)
With the remarkable advancement of modern medicine as well 
as economic development, human longevity and the prevalence 
of chronic diseases due to the aging process have increased. 
Osteoporosis is one representative disease that occurs in the 
elderly, and according to the Korean National Health and 
Nutrition Examination Survey in 2008, prevalence rates of 
osteoporosis and osteopenia were reported as 32.6% and 45.5%, 
respectively, in women aged 50 years or older [1]. It is therefore 
essential to prevent the occurrence of bone fractures and 
osteoporosis, among which incidence rates have abruptly 
increased in middle-aged and elderly individuals, by maintaining 
a healthy skeletal structure during the 20s, the time when 
maximal bone mass is achieved [2].
However, in an environment where slender women are favored 
from a social perspective, bone mineral density has been 
contradictorily reported to be lower in women in their 20s who 
are highly interested in body weight control as compared to those 
in their 30s [3]. It is therefore imperative that young women 
secure maximal bone mass through healthy dietary habits and 
living habits [4]. Factors affecting bone mineral density include 
the following: age of menarche [5], body weight, amount of 
muscle, BMI [6], smoking [7], estrogen and progesterone status 
[8], and dietary intakes of vitamin D [9], isoflavones [10] and 
vitamin K [11]. Particularly in association with bone metabolism, 
vitamin K plays an essential role as a coenzyme during the 
carboxylation of γ-glutamic acid within the protein osteocalcin 
[12]. Carboxylated osteocalcin binds to hydroxyapatite and is 
thereby involved in bone formation. Serum osteocalcin is used 
as a bone metabolism marker that is associated with the 
homeostasis of bone formation [13].
The percentage of undercarboxylated osteocalcin (%ucOC) is 
referred to as the ratio of osteocalcin released to the peripheral 
blood in a non-carboxylated state, and it has a negative 
correlation with vitamin K nutritional status [14]. It is therefore 
used as a sensitive marker of bone metabolism in association 
with vitamin K deficiency [15,16].
According to studies on correlations between vitamin K and 
bone mineral density, there was a positive correlation between 
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vitamin K intake level and bone mineral density and a negative 
correlation with incidence of pelvic bone fracture in women 
[17,18]. In addition, it was also been reported that %ucOC 
decreased following supplementation of vitamin K1 in adult 
women in their 20s [19]. According to animal experiments, 
supplemental vitamin K suppressed the formation of osteoclasts 
and facilitated apoptosis in rats. This eventually led to decreased 
occurrence of bone loss [20]. To explain the mechanisms by 
which vitamin K is involved in bone metabolism, its relationship 
with cytokines as well as action as a coenzyme have been 
proposed. According to the Framingham Offspring Cohort cross- 
sectional study, following the measurement of vitamin K levels 
in subjects in a community-based setting, proinflammatory 
cytokines such as IL-6, intercellular adhesion molecule-1 (ICAM-1), 
and tumor necrosis factor receptor 2 (TNFR2) were found to 
be negatively correlated with vitamin K [21]. Furthermore, 
according to Shea et al. [22], the concentration of serum high 
sensitivity C-reactive protein (hs-CRP), a sensitive inflammatory 
marker, had a negative correlation with serum vitamin K concen-
tration. Moreover, according to a cross-sectional study conducted 
in elderly individuals, there was a positive correlation between 
osteoprotegerin, an inflammatory marker suppressing bone loss 
reactions, and vitamin K. This implies that vitamin K is involved 
in inflammatory responses associated with bone metabolism. In 
Korea, however, there are still an insufficient number of studies 
on the relationship between vitamin K nutritional status, 
inflammation indicators, and bone mineral density.
Given the above background, we examined the relationships 
between %ucOC, hs-CRP (a proinflammatory marker), and bone 
mineral density in women in their 20s in whom maximal bone 
mass is formed. Thus, we attempted to provide baseline data 
for nutritional education on the maintenance of bone health in 
order to prevent osteoporosis in women.
Subjects and Methods
Subjects 
The current study was approved by the Institutional Review 
Board (IRB) of Wonkwang University Hospital, and was 
conducted in women in their 20s from July to September of 2009. 
Of the 86 subjects who submitted a written informed consent, 
11 had study data that were incompletely collected. Seventy-five 
subjects were finally enrolled in the current study.
Methods
Physical examination
The height and weight of subjects were measured using an 
automatic measurer, a DS-102 (Jenix Co, Korea). Body mass 
index (BMI), body fat amount, and its percentage were measured 
using an Inbody 3.0 (Biospace Co, Korea), for which the subjects 
wore minimal clothing by taking off their shoes and socks and 
removing metal items.
Measurement of bone mineral density
To measure bone mineral density, an Osteo pro smart (Bio 
medical technology Co, Korea) device, which is an automatic 
measurer of bone mineral density, was used. Bone mineral 
density was measured by a quantitative ultrasonographic method 
based on decreased velocity of ultrasound that passes bone tissue. 
Data such as height, weight, date of birth, sex, and foot size 
were entered for the measurement of bone mineral density. In 
terms of body positioning, the knees were bent at a right angle 
in a sitting position and then the right ankle was measured in 
such a condition that the calf and foot formed a right angle.
Biochemical assay
Venous blood samples were taken from the subjects after more 
than a 12-hr fasting state. The samples were centrifuged and the 
serum was isolated accordingly. Blood glucose, total cholesterol, 
triglyceride (TG), total protein (TP), and albumin were measured 
using a Mindray BS-220 (Mindray, China).
Measurements of serum osteocalcin and undercarboxylated 
osteocalcin
The concentrations of osteocalcin and undercarboxylated 
osteocalcin (ucOC) in the serum were measured using a Takar 
kit and an Elisa Reader (Molecular Devices, USA). Percent ucOC 
was also calculated as shown below: 




The %ucOC was analyzed based on tertiles. In each group, 
the first, second, and third teritiles of %ucOC were < 19.34%, 
19.34-32.01%, and > 32.01%, respectively.
Measurement of serum hs-CRP
hs-CRP was measured using a Hitachi 7600-110 (Hitachi, 
Japan) based on optical density methods with Pureauto S CRP 
Latex.
Dietary assessment
Evaluations of food intake were performed via interviews by 
investigators who had been trained on the 24-hr recall method. 
To accurately determine food intake, amounts were estimated by 
eye measurements using food models. All analyses were 
performed using Can-pro 3.0; a computer-aided nutritional 
analysis software program developed by the Korean Nutrition 




T 1 (n = 24) T 2 (n = 26) T 3 (n = 25) Total (n = 75)
Age (yr) 21.25 ± 1.87
4) 21.65 ± 2.10 22.12 ± 2.3 21.68 ± 2.13 1.030
Height (cm) 161.55 ± 5.78 160.42 ± 4.46 161.70 ± 5.32 161.21 ± 5.16 0.462
Weight (kg) 55.66 ± 6.98 55.49 ± 6.47 53.96 ± 6.16 55.04 ± 6.49 0.509
BMI (kg/m
2)
2) 21.38 ± 2.96 21.53 ± 2.07 20.63 ± 1.99 21.18 ± 2.37 0.359
Muscle mass (kg) 37.86 ± 4.19 36.88 ± 3.52 36.34 ± 3.60 37.01 ± 3.77 1.024
Body fat mass (kg) 15.58 ± 5.70 16.30 ± 4.18 15.31 ± 3.74 15.74 ± 4.55 0.321
% Body fat 27.48 ± 7.27 29.02 ± 5.04 28.13 ± 4.67 28.23 ± 5.70 0.450
WHR
3) 0.81 ± 0.05 0.81 ± 0.04 0.80 ± 0.03 0.81 ± 0.04 0.288
1) %  Undercarboxylated  Osteocalcin  :  Tertile  1  < 19.34%,  Tertile  2  :  19.34% - 32.01%,  Tertile  3  > 32.01%
2) Body  mass  index
3) Waist-Hip  Ratio
4) Mean ± SD
* P < 0.05  by  F-test
Significance  as  determined  by  ANOVA-test




T 1 (n = 24) T 2 (n = 26) T 3 (n = 25) Total (n = 75)
T-score 1.06 ± 1.67
2)a 0.14 ± 1.56
b -0.03 ± 1.66
b 0.38 ± 1.68 3.174*
Z-score 1.09 ± 1.68
a 0.18 ± 1.55
 ab 0.01 ± 1.67
b 0.41 ± 1.68  3.104*
OI
3) 54.98 ± 8.38
a 50.28 ± 7.86
ab 49.27 ± 7.64
b 51.44 ± 8.23 3.577*
SOS
4) 1374.55 ± 13.75
a 1366.96 ± 13.34
ab 1362.34 ± 10.31
b 1367.85 ± 13.36  5.883*
1) %  Undercarboxylated  Osteocalcin  :  Tertile  1  < 19.34%,  Tertile  2  :  19.34% - 32.01%,  Tertile  3  > 32.01%
2) Mean ± SD
3) OI  :  Osteoporosis  index
4) SOS  :  Speed  of  sounds
* P < 0.05 
Significance  as  determined  by  ANOVA-test
a,b Values  with  different  letters  within  the  same  line  are  significantly  different  from  each  other  by  Tukey’s  test  at  P =0 . 0 5 .
Table 2. Bone mineral density of the subjects by % Undercarboxylated Osteocalcin 
database was combined with that of the Rural Development 
Administration [23] and the USDA National Nutrient Database 
[24]. The standard guidelines for energy and nutrient intakes were 
based on estimated energy requirements (EER), estimated 
average requirements (EAR), and adequate intakes (AI). The 
percentages of recommended intake were analyzed to assess 
nutritional quality [25]. 
Statistical analysis
Statistical analyses were performed using SPSS (Statistical 
Package for Social Science) 12.0. Measurements are expressed 
as the mean and SD (standard deviation). ANOVA was 
performed to assess statistical significance depending on %ucOC 
between the three groups. For an inter-group analysis, a post-hoc 
analysis was performed with Tukey’s test. Multiple regression 
analysis was used to assess associations between biochemical 
indicators (serum %ucOC, cholesterol, and triglycerides) and the 
inflammatory marker hs-CRP, as well as the status of bone 
mineral density. The covariates that were considered in these 
models included age and body mass index (BMI). Statistical 
significance was set at P <0 . 0 5 .
Results
General characteristics and physical examination
Based on tertiles of %ucOC, the subjects’ general characteristics 
and physical examination findings were analyzed. The results are 
presented in Table 1. Between the three groups, there were no 
significant differences in age, height, amount of muscle, amount 
of body fat, waist to hip ratio, percentage of body fat, or BMI. 
Mean BMI was measured as 21.18 ± 2.37 kg/m
2, which was 
within the normal range [26].
Analysis of bone mineral density
The results for bone mineral density measurements are 
presented in Table 2. The T-scores for the first and third tertiles 
were 1.06 and -0.03, respectively. These results indicate that 
T-scores were significantly lower as %ucOC values increased 
(P < 0.05). In the group where %ucOC values corresponded to 
the highest tertiles, Z-scores, OI (Osteoporosis index), and SOS 
(Speed of sound) were significantly lower as compared to 




T 1 (n = 24) T 2 (n = 26) T 3 (n = 25) Total (n = 75)
Glucose  (mg/dl) 91.00 ± 7.02 94.42 ± 5.83 90.20 ± 6.09  91.92 ± 6.50
2) 3.223*
T-Chol (mg/dl)
3) 166.29 ± 24.89 170.38 ± 30.80 162.12 ± 25.45 166.32 ± 27.11  0.586
TG (mg/dl)
4) 70.21 ± 22.57 74.31 ± 41.34 65.60 ± 25.16 70.09 ± 30.89  0.500
TP (mg/dl)
5) 7.11 ± 0.43 7.29 ± 0.45 7.13 ± 0.47 7.18 ± 0.46  1.200
Albumin  (g/dl) 4.52 ± 0.24 4.54 ± 0.22 4.51 ± 0.25 4.52 ± 0.24  0.090
HDL-Chol (mg/dl)
6) 30.53 ± 12.44
a 37.42 ± 10.73
a 45.31 ± 6.66
b 37.84 ± 11.73  12.881***
LDL-Chol (mg/dl)
7) 122.38 ± 31.58 118.30 ± 34.79 104.56 ± 28.32 115.03 ± 32.21  2.145
OC,ucOC.- test
OC (ng/ml
8) 17.52 ± 5.14
a 10.81 ± 3.32
ab 8.10 ± 5.28
b 12.06 ± 6.04 26.604***
ucOC (ng/ml)
9) 2.52 ± 0.73
a 2.65 ± 0.81
ab 4.39 ± 3.35
b 3.19 ± 2.18  6.541**
hs-CRP (mg/dl) 0.04 ± 0.02 0.07 ± 0.04 0.11 ± 0.18 0.07 ± 0.11 0.354
1) %  Undercarboxylated  Osteocalcin  :  Tertile  1  < 19.34%,  Tertile  2  :  19.34% - 32.01%,  Tertile  3  > 32.01% 
2) Mean ± SD
3) T-Chol  :  Total  Cholesterol
4) TG  :  Triglyceride
5) TP  :  Total-Protein
6) HDL-Chol  :  High  Density  Lipoprotein-Cholesterol
7) L D L - C h o l :  L o w  D e n s i t y  L ip o p r o t e in - C h o l e s t e r o l
8) Osteocalcin
9) Undercarboxylated  Osteocalcin
* P < 0.05,  ** P < 0.01,  *** P < 0.001 
Significance  as  determined  by  ANOVA  -  test
a, b, c values  with  different  letters  within  the  same  line  are  significantly  different  from  each  other  by  Tukey’s  test  at  P =0 . 0 5 .



















2) 1616.02 ± 398.07
a  77 1589.27 ± 525.94
b  76 1245.76 ± 453.06
b  59 1483.33 ± 487.85
5)  4.941*
Protein (g) EAR
3) 59.58 ± 17.48
a  170 59.27 ± 20.33
b  169 44.41 ± 16.56
b  126 54.42 ± 19.35  5.644*
Fat (g) 52.49 ± 17.62
a 48.44 ± 21.07
ab  35.88 ± 17.93
b  45.55 ± 20.02  5.143**
Carbohydrate (g) 221.81 ± 68.70  228.69 ± 81.87  186.53 ± 76.88  212.43 ± 77.43  2.218
Fiber (g) AI
4) 16.08 ± 6.49  64 15.32 ± 9.47  61 12.05 ± 6.15  48 14.48 ± 7.66  1.984
Calcium (mg) EAR 407.01 ± 148.11 70 453.26 ± 272.21 78 318.17 ± 140.47  55 393.43 ± 203.67  3.041
Phosphorus (mg) EAR 857.50 ± 221.64
a  148 857.47 ± 332.07
a  148 635.58 ± 243.55
b  110 783.52 ± 287.84  5.564**
Iron (mg) EAR 10.71 ± 3.63
ab  97 12.71 ± 7.89
a  116 8.31 ± 2.70
b 76 10.60 ± 5.55  4.382*
Sodium (mg) AI 3620.30 ± 1220.05  241 3324.43 ± 2479.47  222 2807.04 ± 1299.30  187 3246.64 ± 1788.80  1.314
Potassium (mg) AI 2075.37 ± 699.56  44 2130.76 ± 1142.40  45 1819.63 ± 987.10  39 2009.33 ± 963.21  0.743
Zinc (mg) EAR 7.12 ± 2.53  102 7.06 ± 2.50  101 5.63 ± 1.88  80 6.60 ± 2.39  3.298*
Vitamin A (μgRE) EAR 775.85 ± 432.98  169 632.91 ± 571.64  138 512.48 ± 277.46  111 638.51 ± 452.91  2.137
Vitamin B1  (mg) EAR 1.04 ± 0.38  116 1.09 ± 0.58  121 0.80 ± 0.38  89 0.89 ± 1  2.841
Vitamin B2 (mg) EAR 1.00 ± 0.89  98 1.26 ± 1.38  126 0.75 ± 0.40  75 01.00 ± 0.89  2.198
Vitamin B6  (mg) EAR 1.68 ± 0.70
ab  140 1.81 ± 0.81
a  151 1.28 ± 0.45
b  107 1.59 ± 0.70  4.319*
Niacin (mg) EAR 12.09 ± 4.07  110 14.08 ± 6.60  128 11.56 ± 7.01  105 12.60 ± 6.09  1.226
Vitamin C (mg) EAR 60.85 ± 23.79  81 69.56 ± 66.80  93 50.86 ± 28.10  68 60.54 ± 44.72  1.119
Folate (μg) EAR 221.22 ± 111.42  69 201.70 ± 124.22  63 154.54 ± 69.22  48 192.23 ± 106.82  2.656
Vitamin E (mg) AI 15.23 ± 8.49  15 12.20 ± 6.78 12 11.10 ± 7.64  11 12.80 ± 7.59  2.004
Vitamin K (μg) AI 94.88 ± 51.48
a 146 73.85 ± 45.15
ab 114 62.58 ± 39.92
b 96 76.82 ± 46.97 3.146*
Cholesterol (mg) 328.05 ± 119.31  290.37 ± 161.48  226.21 ± 164.87  281.04 ± 154.31  2.879
C: P: F (%)
6) 54 : 15 : 30 58 : 15 : 27 58 : 14 : 27 57 : 15 : 28
1) %  Undercarboxylated  Osteocalcin  :  Tertile  1  < 19.34%,  Tertile  2  :  19.34% - 32.01%,  Tertile  3  > 32.01% 
2) EER  :  Estimated  Energy  Requirements
3) EAR  Estimated  Average  Requirements
4) A I  :  A d e q u a t e  I n t a k e
5) Mean ± SD
6) C :  P :  F  ( % )  :  C a r b o h y d r a t e  :  P r o t e i n  :  F a t
* P < 0.05,  ** P < 0.01
Significance  as  determined  by  ANOVA-test





  Age 0.014 0.908
  BMI - 0.218 0.065
  Triglyceride - 0.070 0.551
Model 2
  Age 0.006  0.959
  BMI - 0.220 0.065
  Cholesterol 0.008 0.945
Model  3
  Age - 0.053 0.652
  BMI - 0.154 0.194
  SOS
2) - 0.249 0.043
Model  4
  Age - 0.007 0.952
  BMI - 0.193 0.096
  hs-CRP 0.260 0.025
1) %  ucOC  :  %  Undercarboxylated  Osteocalcin
2) SOS  :  Speed  of  sound 
Table 5. Associations between serum %ucOC and biochemical markers and 
bone mineral density 
Biochemical assessment
Blood glucose, total cholesterol, triglycerides, total protein, and 
albumin were measured in the study subjects and the results are 
presented in Table 3. The first, second, and third tertiles of blood 
glucose were 91.00 ± 7.02 mg/dl, 94.42 ± 5.83 mg/dl, and 90.20
± 6.09 mg/dl (P< 0.05), respectively, and were in normal range. 
There were no significant differences in total cholesterol, 
triglyceride, total protein, and albumin between the three groups. 
Concentrations of osteocalcin and non-carboxylated osteocalcin 
were 17.52 ± 5.14 ng/ml and 2.52 ± 0.73 ng/ml in the highest 
tertile group, and 8.10 ± 5.28 ng/ml and 4.39 ± 3.35 ng/ml in the 
lowest tertile group, respectively, and there were significant 
difference between the groups (P < 0.001,  P < 0.01). Tertile 
values of serum hs-CRP showed an increasing tendency as values 
of %ucOC increased; the first, second, and third tertiles of serum 
hs-CRP were 0.04 ± 0.02 mg/dl, 0.07 ± 0.04 mg/dl, and 0.11 ±
0.18 mg/dl, respectively, but these were not statistically 
significant.
Assessment of daily intake 
Inter-group comparisons of nutrient intake amounts depending 
on values of %ucOC are presented in Table 4. Calorie intake 
and protein intake were found to be highest in the group where 
values of %ucOC were lowest. The first, second, and third tertile 
values of daily vitamin K intake were measured as 94.88 ± 51.48 
μg, 73.85 ± 45.15 μg, and 62.58 ± 39.92 μg, respectively, and 
were significantly different (P < 0.05). There were also 
significant differences in intake amounts of nutrients such as iron, 
phosphorus, zinc, and vitamin B6 between the classified groups 
based on values of %ucOC (P< 0.05). Following the calculations 
of percentages of recommended nutrient intakes, all study 
subjects were found to have intakes of protein, phosphorus, 
vitamin A, vitamin B2, niacin, vitamin B6, and vitamin B1 that 
were greater than the recommendations. As compared to the 
recommendations, however, all the study subjects consumed 
insufficient amounts of calcium, folic acid, and vitamin C. 
Correlations between serum %ucOC, inflammatory markers, and 
bone mineral density
We examined the relationships between %ucOC, biochemical 
markers, and bone mineral density, and the results are presented 
in Table 5. There was no association between serum %ucOC 
and serum triglycerides or between serum %ucOC and 
cholesterol, after adjusting for covariates. There was a negative 
correlation between serum %ucOC and hs-CRP. However, there 
was a positive correlation between serum %ucOC and bone 
mineral density, which was measured by an ultrasonographic 
method.
Discussion
We examined concentrations of serum hs-CRP, an inflam-
matory marker, along with bone mineral density and vitamin K 
nutritional status in young women in their 20s. Then, we also 
examined the relationships between these parameters. The 20s 
is the period of age in which bone mass reaches a maximum. 
During this period, bone health and nutritional status are 
important to prevent osteoporosis during the elderly years [27]. 
In the current study, the mean T-score of the study subjects was 
0.38. In particular, in the group with the highest %ucOC and 
where the degree of vitamin K nutritional status was relatively 
lower, the T-score was measured as -0.03. This value corres-
ponded to the normal range according to WHO criteria. It is 
presumed, however, that further risks of developing osteopenia 
would increase considering that the enrolled subjects were 
women in their 20s who maintained a maximal degree of bone 
mass. 
As a marker indicating bone formation, osteocalcin is a 
bone-specific protein composed of 49 amino acids. It is also one 
of the non-collagen proteins forming bone matrix, which is used 
as a marker to predict degree of bone formation [28-30]. In regard 
to the concentration of serum osteocalcin, following the synthesis 
of osteocalcin in osteoblasts, osteocalcin accumulates in the bone 
matrix and its residual amount is measured following its release 
into the blood. Accordingly, an increased concentration of serum 
osteocalcin is indicative of increased bone formation [31]. In our 
study, the mean concentration of serum osteocalcin was 12.06 
ng/ml. This value was relatively higher than 11.8 ng/ml, as 
measured by Hong [32] in postmenopausal women, and 8.30 
ng/ml as measured by Sung et al. [33]. These results indicate 
that degrees of bone formation are relatively higher in younger 512 Vitamin K status, bone mineral density, and hs-CRP
women. 
In association with the maintenance of a healthy skeletal 
structure, protein plays a key role in forming and then 
maintaining maximal bone mass. Yet, excessive intake of animal 
protein decreases calcium absorption from the kidneys and this 
has a detrimental effect on the formation of skeletal structure 
[34]. In this study, when compared with the EAR for protein 
(35 g), the subjects were found to have a protein intake ratio 
of 155.48%. Intake amounts of essential nutrients for the 
formation of skeletal structure, including calcium, zinc, folic acid, 
and vitamin C, were all found to be insufficient as compared 
to their EAR values. In particular, in the group where %ucOC 
was highest, degrees of nutrient insufficiency were also found 
to be relatively higher. Accordingly, in women in their 20s, in 
whom maximal bone mass is reached, an appropriate intake of 
protein is mandatory. Therefore, these subjects should be 
instructed to consume vitamins and minerals that might be easily 
deficient. 
In our study, vitamin K was found to be appropriately 
consumed at an amount of 78.82 μg, as compared to the mean 
daily AI of 65 μg proposed by the KDRIs. To date, not many 
studies have been conducted to analyze the status of vitamin K 
intake in Korea. According to Hong [32] who examined 
postmenopausal women, vitamin K was found to be consumed 
at an amount of 379 μg. According to a study conducted to 
analyze vitamin K intake in young Japanese women, the average 
intake was 155.9 μg [35], and it was approximately 80 μg in 
American women under age 45 [36]. In our study, the amount 
of vitamin K intake was relatively lower than the results of 
previous studies. This might be due to factors associated with 
differences in dietary habits between countries, a deficiency of 
green leafy vegetables containing higher amounts of vitamin K, 
and lower food intake because of excessive interest in body 
weight control in younger women. 
In such a condition where osteocalcin is not carboxylated due 
to the depletion of vitamin K, osteocalcin is not effective for 
bone formation and is released to the blood as a form of ucOC. 
ucOC has therefore been used as a marker indicating vitamin 
K nutritional status [37]. In recent years, however, the proportion 
of uncarboxylated osteocalcin has been measured in proportion 
to the amount of osteocalcin, and this is referred to as %ucOC. 
Therefore, %ucOC has been proposed as a more sensitive 
indicator of vitamin K nutritional status [37]. In the current study, 
the degree of vitamin K intake was relatively lower in the group 
where %ucOC was relatively higher as compared to other groups. 
These results are in agreement with previous reports demons-
trating a negative correlation between vitamin K intake and 
%ucOC [38,39]. However, the young women in the present study 
had a relatively high degree of undercarboxylated serum 
osteocalcin (mean 32.5%) than subjects in other studies (21.9% 
for healthy girls in Denmark [38], 7.5% for healthy adults [19], 
13.0% for postmenopausal women in the USA [39]). 
According to a cohort study that was conducted to examine 
the correlation between proximal femur fracture and level of 
vitamin K intake in the elderly, incidence of fracture was 
relatively lower in subjects with higher intakes of vitamin K 
[16,40]. It was also reported that risks of developing hip joint 
fractures were decreased following the intake of vitamin K [41]. 
Furthermore, it is recommended that vitamin K should be 
ingested at an amount of > 500 μg/day for the prevention of bone 
fractures [42]. In the current study, which was conducted in 
women in their 20s, there was a negative correlation between 
%ucOC and bone mineral density, which is in agreement with 
previous reports that studied elderly patients and patients with 
bone fractures. Therefore, in women in their 20s during which 
maximal bone mineral density is reached, special attention should 
be given to vitamin K intake to ensure adequate stores of the 
nutrient.
Osteoporosis is a disease occurring as a result of imbalances 
in bone remodeling due to the predominance of bone resorption 
over bone formation, during which various key factors are involved 
in bone physiology and regeneration [43]. Pro-inflammatory 
cytokines involved in inflammatory responses, such as interleukin 
(IL)-6 and CRP, have also been revealed to regulate bone 
metabolism even in healthy individuals without immunological 
diseases [44]. IL-6 is synthesized from osteoblasts, monocytes, 
and T-cells and it facilitates the differentiation and activation 
of osteoclasts [45]. C-reactive protein (CRP) belongs to the 
pentaxin family of immune-recognition proteins, and it is a 
sensitive marker for systemic inflammatory responses. Further-
more, it was recognized that IL-1, IL-6, and TNF-α are regulatory 
factors for the synthesis of CRP [46,47]. According to Bae et 
al. [48] who examined the correlation between bone mineral 
density and hs-CRP, as concentrations of serum hs-CRP 
increased, bone mineral density decreased and bone turnover rate 
was increased [49]. These authors therefore proposed that serum 
hs-CRP is closely associated with bone metabolism and 
inflammatory responses. According to a study on correlations 
between vitamin K and inflammatory responses, there were 
positive correlations between %ucOC and two inflammatory 
markers (IL-6 and hs-CRP). Moreover, in the current study 
following regression analysis, as values of %ucOC indicating 
vitamin K deficiency increased, concentrations of serum hs-CRP 
also significantly increased. Because there remains an insufficient 
amount of definite data on inflammatory markers and mechanisms 
associated with vitamin K, further studies are needed.
The limitations of the current study are as follows: The study 
was a cross-sectional design and it did not clarify whether there 
are causal relationships between vitamin K nutritional status, 
bone mineral density, and inflammatory markers. Further studies 
are therefore warranted to clarify any causal relationships. 
Nevertheless, the current study is of great significance in that 
it includes an analysis of correlations between vitamin K 
nutritional status and inflammatory responses in healthy adult 
women who had not yet developed specific types of bone disease.Misung Kim et al. 513
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